Cardiol Therapeutics Inc. (OTCMKTS:CRTPF – Get Free Report)’s share price shot up 12.6% during trading on Thursday . The stock traded as high as $1.29 and last traded at $1.25. 3,382,043 shares changed hands during trading, an increase of 4,941% from the average session volume of 67,097 shares. The stock had previously closed at $1.11.
Cardiol Therapeutics Price Performance
The stock has a 50 day moving average price of $1.02 and a two-hundred day moving average price of $1.04.
About Cardiol Therapeutics
Cardiol Therapeutics Inc is a clinical-stage biotechnology company focused on the development of novel immuno-lipid therapies for treating heart failure and inflammation-related cardiovascular diseases. The company’s proprietary platform is built on synthetic formulations of cardiolipin, a naturally occurring mitochondrial lipid known to play a key role in cellular energy production and inflammatory regulation. By harnessing the anti-inflammatory properties of cardiolipin derivatives, Cardiol aims to address unmet needs in acute and chronic cardiovascular conditions.
Cardiol’s lead product candidate, CT-1 Microspheres, is designed for intravenous administration to hospitalized patients with acute decompensated heart failure.
Read More
Receive News & Ratings for Cardiol Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiol Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
